针对性补充治疗在淋巴细胞病变:一个全面的审查
Micaela Gentile1, Lucio Manenti2
1UO Nefrologia, Dipartimento di Medicina e Chirurgia, Università di Parma, 43126 Parma, Italy.
Journal of clinical medicine
|February 13, 2025
概括
补体系统对免疫力至关重要,当过度激活时,可以导致损伤 (球球病变). 研究探讨了针对新型淋巴结膜病治疗的补充途径.
科学领域:
- 免疫学 免疫学 免疫学
- 腎臟病學 (nephrology) 是一種醫學.
- 补充系统生物学 补充系统生物学
背景情况:
- 补体系统是天生的免疫力的一个关键部分,涉及触发炎症的蛋白质.
- 虽然对宿主防御至关重要,但不受控制的补充激活会导致组织损伤,包括脏.
- 淋巴结核病是一种多种原因的病,在病变过程中越来越多地认识到补体激活.
研究的目的:
- 审查补充通路和质细胞病变之间的复杂关系.
- 突出补充激活在病发展中的作用.
- 探索潜在的治疗策略,以补充系统为目标,以治疗淋巴结膜病变.
主要方法:
- 关于补充激活和细胞病变的研究的综合文献综述.
- 分析将补充通路与病理联系起来的机制.
- 检查现有和新兴的治疗干预措施,包括eculizumab.
主要成果:
- 不适当的补充激活是淋巴结膜病变发病的一个重要驱动因素.
- 针对特定的补充通路提供了一个有前途的治疗途径.
- 埃奎利祖马布已在治疗非典型的血溶性尿素性综合征等补充介导疾病方面表现出有效性.
结论:
- 了解补充体和质细胞病变之间的相互作用对于推进脏疾病治疗至关重要.
- 向补充抑制代表了针对特定结晶体病的显著治疗发展.
- 对补充剂调制的进一步研究有望改善病患者的治疗结果.
相关概念视频
Open Angle Glaucoma: Treatment
386
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
386
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Angle Closure Glaucoma: Treatment
432
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
432
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
Renal Corpuscle
1.6K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
1.6K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
131
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
131


